The significance of measurement of serum unbound bilirubin concentrations in high-risk infants.
BACKGROUND
In the management of neonatal hyperbilirubinemia, total bilirubin (TB) concentration is not specific enough to predict the brain damage caused by bilirubin toxicity. Unbound bilirubin (UB) easily passes the blood-brain barrier and causes neurotoxicity. We aimed to evaluate whether serum UB concentration would be a useful predictor of bilirubin encephalopathy in high-risk infants.


METHODS
We measured the serum TB and UB concentrations of 388 newborn infants treated with phototherapy or exchange transfusion for their hyperbilirubinemia at Takatsuki General Hospital between January 2002 and October 2003. Peak serum TB and UB levels and UB/TB ratios were studied on each birthweight group: below 1500 g (very low birthweight), 1500 g-2499 g (low birthweight), above 2500 g (normal birthweight); and several clinical factors influencing hyperbilirubinemia were also studied.


RESULTS
Peak serum TB and UB levels increased with increasing birthweight, while UB/TB ratios decreased. The very low birthweight group showed higher UB levels and UB/TB ratios despite lower TB levels in intraventricular hemorrhage or severe infection compared to those in the others. The low birthweight and normal birthweight groups showed higher TB and UB levels in cases of hemolytic disease of the newborn compared to non-hemolytic disease of the newborn cases. Eight of 44 cases showed high UB levels accompanied by abnormal auditory brainstem responses, one of whom subsequently developed ataxic cerebral palsy with hearing loss, whereas the other seven showed transient abnormalities of auditory brainstem responses by the treatment of exchange transfusion or phototherapy.


CONCLUSIONS
The UB measurement was considered to be significant for the assessment of the risk of bilirubin neurotoxicity and the appropriate intervention for hyperbilirubinemia in high-risk infants.
Department of Pediatrics & Neonatology, Takatsuki General Hospital, Takatsuki, Japan. yk-lee@ajk.takatsuki-hp.or.jp
Yong-Kye
YK
Lee
Yasuyo
Y
Daito
Yoshinori
Y
Katayama
Hirotaka
H
Minami
Hirokuni
H
Negishi
D001663:Bilirubin / Q000097:blood*; D002552:Cerebral Ventricles; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D020300:Intracranial Hemorrhages / Q000097:blood / Q000175:diagnosis; D007567:Jaundice, Neonatal / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D007647:Kernicterus / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D008297:Male; D010789:Phototherapy; D012307:Risk Factors
D001663:Bilirubin